MetaCap

Gelteq (GELS) vs Sonoma Pharmaceuticals (SNOA)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.

Summary

Gelteq is the larger company by market cap ($5.9 million vs $5.6 million), about 1.1 times the size.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

GELS-2.02%SNOA-4.92%
+0%-2%-5%
Oct 7, 20261 yearOct 8, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

GELS versus SNOA key metrics
MetricGELSSNOA
Share price$0.5488$1.16
Market cap$5.88M$5.55M
1-day change-1.98%-4.92%
EPS (TTM)$-0.44$-1.22
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
52-week high$2.01$4.30
52-week low$0.387$0.85
Distance from 52-week high-72.70%-73.02%
Average volume2.86M107.65K
Shares outstanding10.71M4.79M
Employees710
SectorHealthcareHealthcare
IndustryDrug Manufacturers - Specialty & GenericDrug Manufacturers - Specialty & Generic

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

About Gelteq

GELS stock →

Gelteq Limited focuses on developing and commercializing white label gel-based delivery solutions for humans and animals in the United States of America, China and Australia. It offers edible gels for prescription drugs, nutraceuticals, pet care, and other products, as well as for sports and over-the-counter products.

Healthcare · Drug Manufacturers - Specialty & Generic · 7 employees

About Sonoma Pharmaceuticals

SNOA stock →

Sonoma Pharmaceuticals, Inc. develops and produces stabilized hypochlorous acid (HOCl) products for wound and eye care, oral and nasal care, podiatry, animal health care, and dermatological conditions in the United States, Europe, Asia, Latin America, and internationally.

Healthcare · Drug Manufacturers - Specialty & Generic · 10 employees

GELS vs SNOA FAQ

Which is bigger, Gelteq or Sonoma Pharmaceuticals?

Gelteq (GELS) is larger, with a market capitalization of $5.88M compared with $5.55M for Sonoma Pharmaceuticals (SNOA).

Are Gelteq and Sonoma Pharmaceuticals in the same industry?

Yes. Both are classified in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector.

More comparisons